8 results

• FTC to Allow Tepezza Manufacturer to be Bought By Amgen Amid Growing Hearing Loss Litigation

  September 12, 2023

  Irvin Jackson

  The FTC has agreed to allow Amgen to buy Horizon, the manufacturer of Tepezza, after proposing a consent decree which seeks to prevent the company from gaining an overwhelming advantage on its competitors.

• FTC Files Lawsuit To Prevent Amgen From Acquiring Manufacturer of Tepezza, Krystexxa

  May 19, 2023

  Irvin Jackson

  The FTC has filed a complaint to stop Amgen from acquiring Horizon Therapeutics, saying it would give the manufacturer a monopoly on certain drugs, like Tepezza.

• Tepezza Hearing Damage Lawsuit Filed Against Makers of Thyroid Eye Disease Drug

  February 16, 2023

  Irvin Jackson

  A Tepezza hearing damage lawsuit claims a woman suffered permanent hearing loss due to the side effects of the thyroid eye disease drug.

• Drug Maker Files Motion to Dismiss Tepezza Lawsuit Over Hearing Loss Warnings

  February 13, 2023

  Irvin Jackson

  Horizon Pharmaceuticals is asking a federal judge to dismiss all Tepezza lawsuits over hearing loss injuries, claiming they are preempted by federal law.

• Tepezza Hearing Loss Claimants Seek To Consolidate 10 Lawsuits Against Horizon Therapeutics Filed in Northern District of Illinois

  January 18, 2023

  Irvin Jackson

  A group of plaintiffs are calling for Tepezza hearing loss lawsuits to be consolidated before one Northern Illinois federal judge for pretrial proceedings.

• Investors File Lawsuit To Prevent Acquisition of Tepezza Manufacturer Horizon Therapeutics

  January 9, 2023

  Irvin Jackson

  Two investors have filed lawsuits to stop the acquisition of Tepezza manufacturer Horizon Therapeutics, claiming the company is hiding material financial projections from shareholders who must approve the deal.

• Horizon Therapeutics Acquired for Nearly $30B Amid Growing Threat of Tepezza Lawsuit Payouts

  December 15, 2022

  Irvin Jackson

  Despite the threat of having to eventually pay Tepezza lawsuit payouts, Amgen has acquired the drug's manufacturer, Horizon Pharmaceuticals for nearly $30 billion.

• Side Effects of Tepezza Caused Irreversible Hearing Loss, Lawsuit Alleges

  November 18, 2022

  Irvin Jackson

  A product liability lawsuit claims the side effects of Tepezza, a thyroid eye disease drug, led to permanent hearing loss.